Этиологическая структура при кандидозных кольпитах

Автор: Омарова Л.С., Сакенова М.Н., Наурызов Н.Н., Кайырбекова К.К., Баймагамбетова Д.Д.

Журнал: Академический журнал Западной Сибири @ajws

Рубрика: Акушерство и гинекология

Статья в выпуске: 1 (62) т.12, 2016 года.

Бесплатный доступ

Короткий адрес: https://sciup.org/140221800

IDR: 140221800

Список литературы Этиологическая структура при кандидозных кольпитах

Мирзабалаева A.K. и Долго-Сабурова Ю.В. Кандидоз гениталий и бактериальный вагиноз в практике акушера-гинеколога//Акушерство и генекология. -2004. -Том 5, № 3. -С. 18-24.
Lichtenstern C. Postoperative bacterial/fungal infections: a challenging problem in critically ill patients after abdominal surgery//Dig. Drug. -2007. -Vol. 24, № 1.
Arendrup M.C. и Perlin D.S. Echinocandin resistance: an emerging clinical problem?//Curr. Opin. Infect. Dis. -2014. -Vol. 27, № 6. -Р. 484-576.
Lewis R.E. Decision making in antifungal monotherapy versus combination therapy//Pharmacotherapy. -2006. -Vol. 26, № 6. -Р. 61-67.
Giraldo Р.С. et al. The effect of "breathable" panty liners on the female lower genital tract//Int. J. Gynaecol. Obstet. -2011. -Vol. 115, № 1.
WHO Strategies for global surveillance of antimicrobial resistance. Report of a technical consultation: WHO, 2013.
Веселов А.В. и др. Fungicidal effect of photodynamic therapy against fluconazole-resistant Candida albicans and Candida glabrata//Клин. Микробиол. и антимикробная химотерапия. -2005. -Том 7, № 1. -С. 68-76.
Panda, A. et al. MALDI-TOF mass spectrometry for rapid identification of clinical fungal isolates based on ribosomal protein biomarkers//J. Microbiol. Methods. -2014. -№ 109. -С. 93-105.
Marinach C. MALDI-TOF MS-based drug susceptibility testing of pathogens: the example of Candida albicans and fluconazole//Proteomics. -2009. -Vol. 20, № 9. -Р. 4627-4658.
Spanu T. et al. Direct maldi-tof mass spectrometry assay of blood culture broths for rapid identification of Candida species causing bloodstream infections: an observational study in two large microbiology laboratories//J. Clin. Microbiol. -2012. -Vol. 50, №
-Р. 176-185.
Idelevich E.A. et al. Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2//PLoS One. -2014. -Vol. 9, № 12. -Р. e114834.
Martinez-Lamas L. et al. Matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometry vs conventional methods in the identification of Candida non-albicans//Enferm. Infecc. Microbiol. Clin. -2011. -Vol. 29, № 8. -Р. 568-640.
Barousse M.M. et al. Vaginal yeast colonisation, prevalence of vaginitis, and associated local immunity in adolescents//Sex. Transm. Infect. -2004. -Vol. 80, № 1. -Р. 48-53.
Linhares L.M. et al. Differentiation between women with vulvovaginal symptoms who are positive or negative for Candida species by culture//Infect. Dis. Obstet. Gynecol. -2001. -Vol. 9, № 4. -Р. 221-226.
Cetin M. et al. Distribution of Candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods//Scand. J. Infect. Dis. -2007. -Vol. 39, № 6-7. -Р. 584-592.
Pirotta M.V., Garland S.M. Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics//J. Clin. Microbiol. -2006. -Vol. 44, № 9. -Р. 3213-3220.
Grigoriou O. et al. Prevalence of clinical vaginal candidiasis in a university hospital and possible risk factors//Eur. J. Obstet. Gynecol. Reprod. Biol. -2006. -Vol. 126, № 1. -Р. 121-126.
Eckert L.O. et al. Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm//Obstet. Gynecol. -1998. -Vol. 92, № 5. -Р. 757-823.
Rosenberg M.J. et al. Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms//Am. J. Public. Health. -1992. -Vol. 82, № 5. -Р. 669743.
Horowitz B.J., Edelstein S.W., Lippman L. Sugar chromatography studies in recurrent Candida vulvovaginitis//J. Reprod. Med. -1999. -Vol. 29, № 7. -Р. 441-444.
Weissenbacher T.M. et al. Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid//Eur. J. Obstet. Gynecol. Reprod Biol. -2009. -Vol. 144, 1, стр. 59-63.
Moraes P.S., de Lima Goiaba S., Taketomi A.E. Candida albicans allergen immunotherapy in recurrent vaginal candidiasis//J. Investig. Allergol. Clin. Immunol. -2000. -Vol. 10, № 5. -Р. 305-314.
Muzny C.A. et al. Lack of evidence for sexual transmission of genital Candida species among women who have sex with women: a mixed methods study//Sex Transm. Infect. -2014. -Vol. 90, № 2. -Р. 165-235.
Amouri I. et al. Epidemiological survey of vulvovaginal candidosis in Sfax//Tunisia. -2011. -Vol. 54, № 5. -Р. e499-505.
De Leon E.M. Prevalence and risk factors for vaginal Candida colonization in women with type 1 and type 2 diabetes//BMC. -2002. -Vol. 2, № 2.
Кира Е.Ф., Муслимова С.З. Современный взгляд на нетрансмиссионные инфекции влагалища и вульвы у женщин репродуктивного возраста//Акуш. и гинекол. -2008. №1. -С.3-6.
Burstein G.R., Workowski K.A. Sexually transmitted diseases treatment guidelines//Curr Opin Pediatr. -2003. -Vol. 15, № 4. -Р. 391-398.
Прилепская В.Н., Байрамова Г.Р. Хронический рецидивирующий вульвовагинальный кандидоз//Consilium medicum. -2004. -№ 7. -Р. 479-481.
Куперт А.Ф., Киборт Р.В., Попова Н.В. и др. собенности клиники и лечения вагинального кандидоза у беременных в зависимости от вида грибов рода Candid//Гинекология. -2004. -№ 4. -Р. 182-184.
Wieten G. et al. Application of pyrolysis mass spectrometry to the classification and identification of mycobacteria//Rev. Infect. Dis. -1981. -Vol. 3, № 5. -Р. 871-878.
Workowski K.A. et al. Sexually transmitted diseases treatment guidelines//MMWR Recomm Rep. -2010. -Vol. 59. -Р. 100-110.

Еще

Статья